Another target of miR-17 is the connective tissue growth factor (CTGF) and thrombospondin-1 which affects myocardial fibrosis and significant expression of miR-17 has been linked to heart failure [61] and hypertrophic cardiomyopathy [62]. Here, THBS1 is linked to heart failure.